Oscar Health (NYSE:OSCR) Share Price Breaks Below Fifty Day Moving Average – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR)’s stock price crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $32.00 and traded as low as $30.60. Oscar Health shares last traded at $31.8060, with a volume of 3,659,010 shares changing hands.

Analyst Ratings Changes

OSCR has been the topic of a number of analyst reports. Piper Sandler dropped their price objective on shares of Oscar Health from $48.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, November 6th. Robert W. Baird upped their target price on shares of Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Raymond James Financial raised their price target on shares of Oscar Health from $34.00 to $42.00 and gave the company an “outperform” rating in a report on Friday, September 18th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $34.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. Finally, Bank of America boosted their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $34.60.

Oscar Health Stock Down 0.9%

The stock’s 50 day simple moving average is $32.00 and its 200 day simple moving average is $24.30. The stock has a market capitalization of $9.82 billion, a P/E ratio of 13.14, a P/E/G ratio of 0.24 and a beta of 2.56. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.14) by $0.63. The business had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.69 billion. Oscar Health had a net margin of 4.90% and a return on equity of 49.39%. The company’s quarterly revenue was up 72.1% compared to the same quarter last year. During the same quarter last year, the company posted ($0.53) earnings per share. As a group, research analysts predict that Oscar Health, Inc. will post 2.48 EPS for the current fiscal year.

Insider Activity

In other Oscar Health news, insider Adam Mcananey sold 9,092 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $285,943.40. Following the transaction, the insider owned 209,004 shares of the company’s stock, valued at $6,573,175.80. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of Oscar Health stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the completion of the transaction, the director owned 112,121 shares of the company’s stock, valued at approximately $3,614,781.04. The trade was a 18.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 over the last three months. Company insiders own 22.64% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors and hedge funds have recently modified their holdings of the business. Assenagon Asset Management S.A. lifted its position in shares of Oscar Health by 107.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock worth $79,867,000 after buying an additional 1,341,716 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after buying an additional 759,837 shares during the last quarter. Halter Ferguson Financial Inc. raised its stake in Oscar Health by 93.3% during the third quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company’s stock worth $37,373,000 after acquiring an additional 584,818 shares during the period. Wedge Capital Management L L P NC bought a new position in Oscar Health in the second quarter worth about $32,855,000. Finally, Bank of America Corp DE boosted its stake in Oscar Health by 205.1% in the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock valued at $32,808,000 after acquiring an additional 1,922,732 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar’s products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.